Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicentre, Single-arm Phase II Trial of Adagrasib in Patients With KRASG12C-mutant NSCLC, Including the Elderly (≥70 Years) or Patients With Poor Performance Status

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05673187
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:41:25.516206+00:00
Published At
2026-04-27T00:00:00+00:00
Record Updated At
2026-04-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["NSCLC Stage IV", "KRAS P.G12C"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-27"
protocolSection.identificationModule.nctId
"NCT05673187"
protocolSection.identificationModule.officialTitle
"A Multicentre, Single-arm Phase II Trial of Adagrasib in Patients With KRASG12C-mutant NSCLC, Including the Elderly (\u226570 Years) or Patients With Poor Performance Status"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • NSCLC Stage IV (protocolSection.conditionsModule.conditions)
  • KRAS P.G12C (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.